In patients with protein C deficiency, oral anticoagulant therapy with warfarin may cause severe skin necrosis known as warfarin induced skin necrosis(WISN). We present a young female patient of PPCM with protein C deficiency and WISN, warfarin was reintroduced and no skin necrosis occured again. Our case serves to alert physicians for prompt investigation of possible underlying thrombophilia in PPCM patients presented with multiple intracardiac thrombi and unexplained skin lesion. Successful readministration of warfarin in patients with a history of WISN is possible by starting at a low dose with gradual dose adjustment as demonstrated in our case.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.